...
首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >Development and Evaluation of Press Coated Tablets of Fexofenadine Hydrochloride as Pulsatile Delivery System
【24h】

Development and Evaluation of Press Coated Tablets of Fexofenadine Hydrochloride as Pulsatile Delivery System

机译:盐酸非索非那定脉冲包衣系统压片的研制与评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Pulsatile drug delivery systems are developed to deliver drug according to circadian behavior of diseases. The product is characterized by a time period of no release (lag time) followed by a rapid and complete drug release as a pulse after the lag time. Thus drug can be delivered at right time, in right amount and at right site of action by use of such approach. These systems are beneficial for drugs with chronopharmacological behavior, where nocturnal dosing is required. Common symptoms of allergic rhinitis ;sneezing, nasal rhinorrhea, red itchy eyes, nasal pruritus and nasal congestion were found to occur most frequently before breakfast and in the morning and least frequently in the middle of the day. An oral press-coated tablet of Fexofenadine HCl was developed by means of wet granulation and direct compression to achieve time-controlled tablet with a predetermined lag time. The preparation of press coated tablet involved preparation of fast dissolving core tablets by wet granulation method, where 60 mg of Fexofenadine HCl was formulated with different types and concentrations of superdisintegrants, and an outer coat which is formulated with different weight ratios of hydrophobic polymer; Ethyl cellulose (EC) and hydrophilic polymer; Hydroxy propyl methylcellulose (HPMC) using direct compression. The Formulation was evaluated on basis of acceptable physical properties and in vitro drug release. The results indicated that press-coated tablet composed of B3 (as core tablet formula) and C2 (as coat formula) gave complete and rapid release of Fexofenadine HCl after 6 hours lag time which is suitable to achieve time-controlled release of Fexofenadine hydrochloride, based on chronopharmaceutical approach for the treatment of morning allergic rhinitis through providing maximum concentration of the drug at time of its maximum need.
机译:开发了脉冲药物输送系统,以根据疾病的昼夜节律行为输送药物。该产品的特征在于不释放的时间段(滞后时间),然后在滞后时间之后以脉冲形式快速而完全地释放药物。因此,通过使用这种方法,可以在正确的时间,正确的量和正确的作用部位递送药物。这些系统对于需要夜间给药的具有时间药理行为的药物非常有用。变态反应性鼻炎的常见症状包括:打喷嚏,鼻流鼻涕,眼睛发红,鼻瘙痒和鼻充血,最常见于早餐前和早晨,最不常见于中午。盐酸非索非那定的口服压片片剂是通过湿法制粒和直接压片制成的,以具有预定滞后时间的时间控制片剂。压制包衣片剂的制备涉及通过湿法制粒制备速溶芯片剂,其中用不同类型和浓度的超崩解剂配制60 mg盐酸非索非那定,并用不同重量比的疏水性聚合物配制外衣。乙基纤维素(EC)和亲水性聚合物;使用直接压缩的羟丙基甲基纤维素(HPMC)。根据可接受的物理性质和体外药物释放评估制剂。结果表明,由B3(作为片剂的核心配方)和C2(作为包衣的配方)组成的压制片剂在经过6小时的滞后时间后,可以完全,快速地释放盐酸非索非那定,这适于实现盐酸非索非那定的时间控制释放,基于计时药物的方法,通过在最大需求时提供最大浓度的药物来治疗早晨过敏性鼻炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号